Altimmune, Inc. closed a $75 million direct offering to fund Phase 3 pemvidutide trials for MASH. Learn more about ALT stock here.
NRG Energy has outperformed NextEra Energy and the S&P 500 over the past five years. Read more on how these two energy giants compare.
Barchart on MSN
1 promising stock that just hit new 52-week highs
Cimpress (CMPR) is trading at a new 52-week high. ・The stock maintains a 100% “Buy” opinion from Barchart with strong ...
In a slight surprise, Fallout season 2 's finale comes bundled with a post-credits scene that both continues the narrative thread of one of the major factions left out of episode 8's runtime as well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results